Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Our services

Out of Hospital COVID Treatment and Eligibility

Certain groups of patients can potentially have monoclonal antibody OR anti-viral treatment out of hospital if they test positive for COVID-19 and fit the criteria. The aim of which is to reduce the need for hospital admission.

Non-hospitalised patients are eligible for treatment if:

  • SARS-CoV-2 infection is confirmed by either: Polymerase chain reaction (PCR) testing OR Lateral flow test (registered via or NHS 119)  AND
  • Symptomatic with COVID-19 and showing no signs of clinical recovery AND
  • The patient is a member of a ‘highest’ risk group

The ‘highest’ risk group includes those with inflammatory conditions that fit the criteria below:

  • Treated with rituximab or other B cell depleting therapy in the last 12 months
  • Active/unstable disease on steroids, cyclophosphamide, tacrolimus, cyclosporin or mycophenolate.
  • Stable disease on either steroids, cyclophosphamide, tacrolimus, cyclosporin or mycophenolate.
  • Patients with active/unstable disease including those on biologic therapy

Patients on Methotrexate, sulfasalazine or hydroxychloroquine, either alone are in combination, are not eligible unless also on biologic therapy.

To receive a rapid PCR test pack which includes instructions on how to access these treatments, please call 119.

Logo on blue with swoosh


Looking down a long bright hospital corridor with treatment rooms on the left and windows on the right. At the bottom of the corridor is one member of staff in a blue nursing uniform

Our Hospitals

Chinese Poland

View all languages >